UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 5 to Schedule TO Tender Offer...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14D-9 (RULE 14d-101...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to Schedule TO Tender Offer...
CUSIP No. 584949101 Page 1 of 6 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to Schedule TO Tender Offer...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to Schedule TO Tender Offer...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to Schedule TO Tender Offer...
Goldfarb Branham LLP is investigating whether the Board of Directors of MedQuist, Inc. (NASDAQ: MEDQ) violated shareholder...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.